INVESTIGATING THE PROGRESSION AND MANAGEMENT OF DIABETIC RETINOPATHY: A CLINICAL PERSPECTIVE

Аннотация

Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus and a leading cause of blindness in working-age adults worldwide. It results from prolonged hyperglycemia, which damages retinal blood vessels, leading to visual impairment. This article explores the progression of diabetic retinopathy, current diagnostic tools, and management strategies. Using clinical observations and recent research data, the methodology involves examining patients at various stages of the disease and assessing the efficacy of interventions such as glycemic control, laser photocoagulation, and intravitreal injections. The results show a strong correlation between early intervention and disease stabilization. This study highlights the need for routine screening and integrated treatment approaches to prevent vision loss due to DR. Key words:Diabetic Retinopathy, Disease Progression, Clinical Management, Retinal Microvascular Complications, Glycemic Control, Vision Loss, Ophthalmic Screening, Anti-VEGF Therapy, Laser Photocoagulation, Diabetic Eye Disease. Introduction: Diabetic retinopathy (DR) represents one of the most significant ophthalmologic complications arising from both Type 1 and Type 2 diabetes mellitus. As the global prevalence of diabetes continues to rise, the incidence of DR is also increasing, posing a serious public health challenge. According to recent epidemiological studies, more than one-third of people with diabetes exhibit signs of retinopathy, with up to 10% experiencing vision-threatening stages such as proliferative diabetic retinopathy (PDR) or diabetic macular edema (DME). The retina, a light-sensitive tissue lining the inner surface of the eye, relies on a dense network of capillaries for its metabolic needs. Chronic hyperglycemia in diabetes damages these microvascular structures, initiating a cascade of pathological changes including capillary occlusion, leakage, and neovascularization. In the early stages, non-proliferative diabetic retinopathy (NPDR) may present asymptomatically, characterized by microaneurysms, dot-blot hemorrhages, and lipid exudates. If left untreated, it may progress to PDR, marked by fragile neovessels prone to bleeding and fibrous proliferation, ultimately leading to retinal detachment and blindness. Given its progressive nature and asymptomatic onset, early detection of DR is crucial. The gold standard for diagnosis remains dilated fundus examination and retinal photography, supplemented by fluorescein angiography and optical coherence https://scientific-jl.com/wsrj 7 7 Volume-39_Issue-2_May-2025 World scientific research journal tomography (OCT). However, access to such diagnostic tools remains limited in many low-resource settings. Treatment strategies for DR have evolved significantly over the past two decades. While glycemic control remains foundational, advances in laser therapy, intravitreal corticosteroids, and anti-vascular endothelial growth factor (anti-VEGF) injections have greatly improved outcomes. These therapeutic options aim not only to halt the progression of the disease but also to preserve and, in some cases, improve vision. The objective of this article is to explore the progression of diabetic retinopathy and evaluate the efficacy of various treatment approaches through a clinical study of patients at different stages of DR. By understanding the pathophysiology, diagnostic challenges, and treatment outcomes, this article aims to contribute to more effective prevention and management strategies for diabetic retinopathy. Methodology This study was conducted at an ophthalmology clinic affiliated with a tertiary care hospital over a period of 18 months, involving 150 patients diagnosed with diabetic retinopathy. Patients were recruited through regular outpatient visits and diabetes screening camps. Ethical approval was obtained from the institutional review board, and informed consent was secured from all participants. Inclusion criteria for the study were patients aged 30–75 years with a confirmed diagnosis of Type 1 or Type 2 diabetes mellitus and evidence of diabetic retinopathy as per the International Clinical Diabetic Retinopathy Disease Severity Scale. Patients with other retinal disorders, previous ocular trauma, or those who had undergone intraocular surgeries unrelated to DR were excluded. Participants underwent a comprehensive ophthalmic examination including best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, intraocular pressure measurement, and dilated fundus examination using binocular indirect ophthalmoscopy. Retinal imaging techniques included color fundus photography and OCT, which provided detailed cross-sectional images of the retina. Fluorescein angiography was used in selected cases to assess the extent of capillary non-perfusion and neovascularization. Participants were categorized into four groups based on the severity of DR: mild NPDR, moderate NPDR, severe NPDR, and PDR. A fifth group included pat